Clinical TrialsSearch results
Number of results: 299
Other
- The Japan Working Group for the Assessment That the Alpha-glucosidase-inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT
- Patients With Myocardial Infarction and IGT
- National Cardiovascular Center
- 2005-08-31
Other
- Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP
- Patients with AMI who are candidates for PCI(first episode of AMI)
- National Cardiovascular Center
- 2005-08-31
Other
- ANTI-PLATELET THERAPY FOR COIL EMBOLIZATION OF UNRUPTURED CEREBRAL ANEURYSMS
- Unruptured cerebral aneurysms
- National Cardiovascular Center
- 2005-09-12
Not yet recruiting
- Basic research on hyperpolarized MR imaging (DNP-MRI) using urologic cancer tissue
- Prostate cancer, bladder cancer, kidney cancer
- nakae Keita
- 2022-02-06
Other
- Exercise and Life Functioning in Patients with Congestive Heart Failure ; A Rehabilitation Cohort Study.
- Patients with congestive heart failure
- Nagoya University School of Health Sciences
- 2007-12-01
Other
- Study of High dose Toremifene for metastatic breast cancer after failure of adjuvant therapy of Aromatase Inhibitor
- First line therapy for recurrence or metastatic postmenopausal breast cancer
- Nagoya University of School of Medicine Breast and Endocrine Surgery
- 2006-10-01
Other
- Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer
- gallbladder cancer
- Nagoya University Hospital
- 2008-07-25
Other
- A prospective multicenter study of combination of peripheral arterial disease in spine surgery and relation with perioperative complications.
- spinal disorder, peripheral arterial disease
- Nagoya university Graduate School of Medicine
- 2009-06-30
Other
- Study of Circulating Progenitor Cells and Myocardial Infarction
- Ischemic heart disease
- Nagoya University
- 2009-04-01
Other
- Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).
- End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)
- Nagoya University
- 2006-10-01